OKYO Pharma Limited Sponsored ADR (OKYO) Live Share Price, Invest From India

OKYO Pharma Limited Sponsored ADR Stock Performance

as on August 29, 2026 at 2:15 pm IST

Day's Low
$1.55
Day's Price Range
$1.67
$1.67
7.19%
Downside
52 Week's Low
52 Week's High
$1.34
52-Week Price Range
$3.20
$1.67
19.75%
Downside
91.62%
Upside

OKYO Pharma Limited Sponsored ADR share price movements today

Previous Close: $1.55
Open: $1.60
Volume: 701.8K
Market Cap: $81.3M
Day's Low - High: $1.55 - $1.67
52 Week Low - High: $1.34 - $3.20

OKYO Pharma Limited Sponsored ADR Historical Returns

1 Month Return: -5.49 %
3 Month Return: -9.36 %
1 Year Return: -31.87 %
3 Year Return: -44.63 %
5 Year Return: 0 %

OKYO Pharma Limited Sponsored ADR Stock Fundamentals & Key Indicators

Check OKYO Pharma Limited Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$81.3M

EPS (TTM)

-0.2391

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.32

Industry PE ratio

-3.0201167315175095

PEG Ratio

0.05276114543462033

EBITDA

-6.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-200.67%

OKYO Pharma Limited Sponsored ADR Stock Valuation

Track how OKYO Pharma Limited Sponsored ADR P/E has moved over time to understand its valuation trends.

OKYO Pharma Limited Sponsored ADR in the last 5 years

Overview
Trends

Lowest (-10.58x)

June 30, 2025

Today (-6.71x)

March 31, 2026

Industry (-3.02x)

March 31, 2026

Highest (-2.56x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -6.71x

OKYO Pharma Limited Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OKYO Pharma Limited Sponsored ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
OKYO Pharma Limited Sponsored ADR	BUY	$81.3M	NA	-6.32	0.00%	NA
Revolution Medicines	BUY	$46.2B	675.69%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$138.7B	173.88%	31.92	86.04%	NA
Moderna	BUY	$59.7B	-62.65%	-7.98	-12.57%	NA
Regeneron	BUY	$85.8B	21.77%	19.9	84.86%	0.44%

Stock Returns calculator for OKYO Pharma Limited Sponsored ADR Stock including INR - Dollar returns

The OKYO Pharma Limited Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

OKYO Pharma Limited Sponsored ADR investment value today

Current value as on today

₹79,924

Returns

-₹20,076

(-20.08%)

Returns from OKYO Pharma Limited Sponsored ADR Stock

-₹26,593 (-26.59%)

Dollar Impact

₹6,518 (+6.52%)

Analyst Recommendation on OKYO Pharma Limited Sponsored ADR Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for OKYO Pharma Limited Sponsored ADR. Average target price of $8.33

OKYO Pharma Limited Sponsored ADR Share Price Target

Get share price movements and forecasts by analysts on OKYO Pharma Limited Sponsored ADR.

What analysts predicted

79.95%UPSIDE

Target Price

$8.33

Current Price

$1.67

Analyzed by

2 Analysts

Target

$8.33

OKYO Pharma Limited Sponsored ADR target price $8.33, a slight upside of 79.95% compared to current price of $1.67. According to 2 analysts rating.

Indian Investors' Interest in OKYO Pharma Limited Sponsored ADR Stock

Search interest for OKYO Pharma Limited Sponsored ADR Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 30, 2026 to August 29, 2026

Change:-10% versus previous 30 day period

OKYO Pharma Limited Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2021	Mar 2022	Sep 2022	Sep 2023	Sep 2024	Jun 2025	Sep 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	-	0	0	-	0	0	0
Operating Income	-2	-6	-5	-8	-3	-4	-2	-6
EBITDA	-2	-6	-5	-8	-2	-3	-	-6
Interest Expense	0	-	-	-	0	0	0	0
Depreciation	0	-	0	0	0	0	-	-
Income Before Tax	-2	-6	-5	-8	-4	-3	-2	-6
Income Tax Expense	0	-1	-	0	-1	-1	-	0
Net Income	-2	-5	-5	-8	-2	-2	-2	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OKYO Pharma Limited Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Jun 2023	Jun 2024	Jun 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	0	0	0	0	-6	-7	0	-6
Operating Income	0	-28	-4	-1	-4	-6	-13	-15	-7	-8
EBITDA	0	26	-4	-1	-4	-6	-13	-15	-7	-8
Interest Expense	-	-	-	0	0	-	0	1	0	0
Depreciation	0	104	-	0	0	0	0	0	0	0
Income Before Tax	0	-28	-4	-1	-3	-6	-13	-16	-7	-8
Income Tax Expense	-	-	-	0	0	0	0	0	-3	0
Net Income	0	-28	-4	-1	-3	-5	-13	-16	-4	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OKYO Pharma Limited Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

	Sep 2021	Mar 2022	Sep 2022	Jun 2023	Sep 2023	Jun 2024	Sep 2024	Jun 2025	Sep 2025	Mar 2026
Net Income	-2	-2	-5	-7	-8	-8	0	-2	-2	-6
Operating Cash Flow	-3	-2	-3	-4	-6	-2	0	-1	-1	-4
Investing Cash Flow	-	0	0	0	-	-	-	0	-	-6
Financing Cash Flow	1	0	1	7	4	2	0	2	4	20
Change in Cash	-1	-2	-1	3	-2	0	0	0	2	10

OKYO Pharma Limited Sponsored ADR Annual Cash Flow

All numbers in Millions USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Jun 2023	Jun 2024	Jun 2025	Mar 2026
Net Income	-28	-4	-1	-3	-6	-13	-16	-7	-8
Operating Cash Flow	-1	-1	-1	-1	-5	-7	-9	-1	-5
Investing Cash Flow	-	0	0	0	0	0	-	0	-6
Financing Cash Flow	-	-	0	7	2	9	6	2	25
Change in Cash	-1	-1	0	6	-4	1	-3	0	13

Mutual Funds that own OKYO Pharma Limited Sponsored ADR Stock

Check out the Mutual Funds with significant holdings in OKYO Pharma Limited Sponsored ADR.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.023037%	12090

Global Institutional Holdings in OKYO Pharma Limited Sponsored ADR

Funds	Holdings
Michael Rockefeller	6.96%

Insights on OKYO Pharma Limited Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, OKYO stock has moved up by 8.4%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 19.0% return, outperforming this stock by 64.1%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 501.7%

About OKYO Pharma Limited Sponsored ADR

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Organisation	OKYO Pharma Limited Sponsored ADR
Headquarters	35a Albemarle St, London, United Kingdom, W1S 4JE
Industry	Biotechnology
CEO	Mr. Robert J. Dempsey M.B.A.
E-voting on shares	Click here to vote

Key Management of OKYO Pharma Limited Sponsored ADR

Name	Title
Dr. Flavio Mantelli M.D., Ph.D.	Chief Medical Officer
Mr. Michael Paul Beck	Founder
Mr. Robert J. Dempsey M.B.A.	CEO & Executive Director
Ms. Keeren Shah	Chief Financial Officer
Dr. Rajkumar Patil Ph.D.	Chief Scientific Officer
Dr. Gary S. Jacob Ph.D.	Chief Development Officer & Director

FAQs

What is OKYO Pharma Limited Sponsored ADR share price today?

OKYO Pharma Limited Sponsored ADR share price today is $1.67 as on August 29, 2026 at 8:45 am IST at the close of the market. OKYO Pharma Limited Sponsored ADR share today touched a day high of $1.67 and a low of $1.55.

What is the 52 week high and 52 week low for OKYO Pharma Limited Sponsored ADR share?

OKYO Pharma Limited Sponsored ADR share touched a 52 week high of $3.20 on January 14, 2026 and a 52 week low of $1.34 on July 16, 2026. OKYO Pharma Limited Sponsored ADR stock price today i.e. August 29, 2026 at 8:45 am IST is closed at $1.67,which is 47.81% down from its 52 week high and 24.62% up from its 52 week low.

What is OKYO Pharma Limited Sponsored ADR's market capitalisation today?

OKYO Pharma Limited Sponsored ADR market capitalisation is $0.00T as on August 29, 2026 at 8:45 am IST.

How to invest in OKYO Pharma Limited Sponsored ADR Stock (OKYO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for OKYO Pharma Limited Sponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in OKYO Pharma Limited Sponsored ADR Shares that will get you 0.8982 shares as per OKYO Pharma Limited Sponsored ADR share price of $1.67 per share as on August 29, 2026 at 8:45 am IST.

What is the minimum amount required to buy OKYO Pharma Limited Sponsored ADR Stock (OKYO) from India?

Indian investors can start investing in OKYO Pharma Limited Sponsored ADR (OKYO) shares with as little as ₹95.368 or $1 (as of August 29, 2026 at 3:01 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in OKYO Pharma Limited Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on August 29, 2026 at 3:01 pm IST). Based on OKYO Pharma Limited Sponsored ADR share’s latest price of $1.67 as on August 29, 2026 at 8:45 am IST, you will get 5.9880 shares of OKYO Pharma Limited Sponsored ADR. Learn more about fractional shares .